Skip to Main Content

Author Details

James K Hicks
H. Lee Moffitt Cancer Center and Research Institute
2004
71
27
PMIDPaper TitleJournal TitlePublished Year
36821823<i>DPYD</i> Testing: Time to Put Patient Safety First.J Clin Oncol2023
37702060Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer.Pharmacogenomics2023
37698371CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial.Pharmacotherapy2023
37350752Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy.Clin Pharmacol Ther2023
37075260Safety Monitoring Activity During EGFR or Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients With Lung Cancer.JCO Oncol Pract2023
37335971Pharmacist-Driven Precision Medicine: A Ferry to Cross the Chasm of Interpreting Biomarker Testing Reports.JCO Oncol Pract2023
37068173Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.Cancer Discov2023
37032427Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.Clin Pharmacol Ther2023
36750665Towards UGT1A1 guided irinotecan dosing.Eur J Hum Genet2023
36765587Treatment Strategies for Non-Small Cell Lung Cancer with Common <i>EGFR</i> Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data.Cancers (Basel)2023
34562070Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.Clin Transl Sci2022
35568931Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.Implement Sci Commun2022
35305098Evaluation of Targeted Next-Generation Sequencing for the Management of Patients Diagnosed with a Cancer of Unknown Primary.Oncologist2022
32860906Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.J Am Acad Child Adolesc Psychiatry2021
33641722Selpercatinib Overcomes CCDC6-RET-Mediated Resistance to Osimertinib.J Thorac Oncol2021
33805415<i>UGT1A1</i> Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation.Cancers (Basel)2021
34526717Structure-based classification predicts drug response in EGFR-mutant NSCLC.Nature2021
34250383Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in <i>KRAS</i> Wild-Type Pancreatic Cancer.JCO Precis Oncol2021
34095711Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice.JCO Precis Oncol2021
34282303Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.Genet Med2021
33288881Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network.Genet Med2021
33428770Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.Clin Pharmacol Ther2021
31549389Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.Clin Pharmacol Ther2020
34164592Clinical Cohort Analysis of Germline <i>EGFR</i> T790M Demonstrates Penetrance Across Ethnicities and Races, Sexes, and Ages.JCO Precis Oncol2020
31664715A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.Clin Pharmacol Ther2020
32015062Pharmacogenomics: An evolving clinical tool for precision medicine.Cleve Clin J Med2020
33315113Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.JAMA Netw Open2020
32854916Erdafitinib Overcomes FGFR3-TACC3-Mediated Resistance to Osimertinib.J Thorac Oncol2020
32308829Development of a Genomic Data Flow Framework: Results of a Survey Administered to NIH-NHGRI IGNITE and eMERGE Consortia Participants.AMIA Annu Symp Proc2020
29997387Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network.Genet Med2019
32984775Precision Pharmacotherapy: Integrating Pharmacogenomics into Clinical Pharmacy Practice.J Am Coll Clin Pharm2019
30158693Correction: Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network.Genet Med2019
28749586Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate Results Into Patient Care.Clin Transl Sci2018
35135101Somatic Sequencing Identifies Trametinib-Responsive Myelodysplastic Syndrome and Finds Acquired Clonal Hematopoiesis of Indeterminate Potential.JCO Precis Oncol2018
30049378Clinical Activity of Crizotinib in Lung Adenocarcinoma Harboring a Rare ZCCHC8-ROS1 Fusion.J Thorac Oncol2018
30228210Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <i>EGFR</i>-Mutant NSCLC.Clin Cancer Res2018
30314519Identification of a novel MTAP-RAF1 fusion in a soft tissue sarcoma.Diagn Pathol2018
29535047Design and rational for the precision medicine guided treatment for cancer pain pragmatic clinical trial.Contemp Clin Trials2018
27997040Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.Clin Pharmacol Ther2017
28294551The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.Clin Transl Sci2017
28179575Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.Oncologist2017
28235141Quantitation of Targetable Somatic Mutations Among Patients Evaluated by a Personalized Medicine Clinical Service: Considerations for Off-Label Drug Use.Pharmacotherapy2017
28957369Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoring.PLoS One2017
28699700Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.Pharmacotherapy2017
28549953Incidence and Triggers of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a Large Cancer Patient Cohort.J Invest Dermatol2017
28838384Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.Lung Cancer2017
27312955Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services.Pharmacotherapy2016
27864204Integrating pharmacogenomics into electronic health records with clinical decision support.Am J Health Syst Pharm2016
27143031Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrations.Pharmacogenomics2016
25973869To the Editor: Clinical utility of warfarin pharmacogenomics.Cleve Clin J Med2015
  • 1 - 50 of 71

Recommended Authors

Alyson L Dickson
Vanderbilt University Medical Center
Career Start Year 2019
Number of shared co-authors 6
Lang Li
College of Medicine, The Ohio State University
Career Start Year 2018
Number of shared co-authors 2
Jyothsna Giri
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2013
Number of shared co-authors 4
Julie A Lynch
VA Salt Lake City Healthcare System (VINCI)
Career Start Year 2013
Number of shared co-authors 4
Marzia Del Re
University of Pisa
Career Start Year 2010
Number of shared co-authors 1
Andrea H Ramirez
Vanderbilt University Medical Center
Career Start Year 2010
Number of shared co-authors 32
Nicholas P Tatonetti
Columbia Universtiy College of Physicians and Surgeons
Career Start Year 2009
Number of shared co-authors 11
Subha Madhavan
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Career Start Year 2009
Number of shared co-authors 10
Ellen M McDonagh
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2008
Number of shared co-authors 18
Catharina Scholl
Federal Institute for Drugs and Medical Devices (BfArM)
Career Start Year 2008
Number of shared co-authors 1
Jason H Karnes
Vanderbilt University Medical Center
Career Start Year 2007
Number of shared co-authors 19
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 1
Kari M Morrissey
Amunix Pharmaceuticals
Career Start Year 2006
Number of shared co-authors 5
June M McKoy
Feinberg School of Medicine, Northwestern University
Career Start Year 2003
Number of shared co-authors 0
Leslie W Chinn
Genentech Inc.
Career Start Year 2003
Number of shared co-authors 3
Rubin Lubomirov
Clinical Development
Career Start Year 2003
Number of shared co-authors 0
Noura S Abul-Husn
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Career Start Year 2002
Number of shared co-authors 20
Lang Li
Harbin Medical University
Career Start Year 2002
Number of shared co-authors 3
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 10
Eric W Klee
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 6
Peter J Hulick
Neaman Center for Personalized Medicine, NorthShore University HealthSystem
Career Start Year 2000
Number of shared co-authors 4
Brian H Shirts
Institute for Public Health Genetics, University of Washington
Career Start Year 2000
Number of shared co-authors 10
Cristina Rodr??guez-Antona
Spanish National Cancer Research Center (CNIO)
Career Start Year 2000
Number of shared co-authors 7
Linnea M Baudhuin
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 6
Susanne B Haga
Duke University School of Medicine
Career Start Year 1999
Number of shared co-authors 11
Shannon Manzi
Department of Pharmacy, Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 9
Bruce C Carleton
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 5
Patricia A Deverka
Deverka Consulting LLC
Career Start Year 1991
Number of shared co-authors 16
Karen E Weck
University of North Carolina at Chapel Hill
Career Start Year 1987
Number of shared co-authors 39
Mark J Ratain
University of Chicago
Career Start Year 1985
Number of shared co-authors 39

Collaborators

Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers 9
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 9
William E Evans
Departments of Oncology. St. Jude Children's Research Hospital
Co-authored papers 9
Larisa H Cavallari
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 8
Kristine R Crews
St. Jude Children's Research Hospital
Co-authored papers 7
Gillian C Bell
Mission Health Personalized Medicine & Pharmacogenomics Program
Co-authored papers 7
Teri E Klein
Stanford University
Co-authored papers 7
Amber L Beitelshees
University of Maryland School of Medicine
Co-authored papers 7
Sony Tuteja
University of Pennsylvania Perelman School of Medicine
Co-authored papers 6
Sara L Van Driest
National Institutes of Health
Co-authored papers 6
Donald M Smith
Georgetown University Medical Center
Co-authored papers 5
Nita A Limdi
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 5
Aniwaa Owusu Obeng
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
James M Hoffman
St. Jude Children's Research Hospital Memphis
Co-authored papers 5
Ulrich Broeckel
Medical College of Wisconsin
Co-authored papers 5
Victoria M Pratt
Indiana University School of Medicine
Co-authored papers 5
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers 5
Cyrine E Haidar
St. Jude Children's Research Hospital
Co-authored papers 5
Ching-Hon Pui
St. Jude Children's Research Hospital
Co-authored papers 4
Mark R Wilkinson
St. Jude Children's Research Hospital
Co-authored papers 4
Donald K Baker
St. Jude Children's Research Hospital
Co-authored papers 3
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Co-authored papers 3
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 3
Ebony B Madden
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 3
Julie A Johnson
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 3
Geoffrey S Ginsburg
National Institutes of Health
Co-authored papers 3
Scott C Howard
College of Nursing
Co-authored papers 3
Jonathan S Schildcrout
Vanderbilt University Medical Center.
Co-authored papers 3
Amanda R Elsey
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 3
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Release 1.2